BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
May 21, 2007
 |  BioCentury  |  Regulation

Limited use of ESAs

Limited use of ESAs

Limited use of ESAs
CMS has proposed limited coverage of ESAs for anemia in cancers where the presence of erythropoietin receptor on either normal tissue/cell lines or malignant tissue/cell lines has been reported in the literature. The agency's proposal is more restrictive than widely accepted treatment guidelines for both...

Read the full 270 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >